Storyboard

America’s first CRISPR trial is still nearly 100% effective 3 years on

Incredible new data presented recently has revealed an experimental CRISPR gene editing therapy is both safe and effective up to three years after treatment. The follow-up results come from one of the longest-running human trials using CRISPR technology to treat a pair of rare genetic blood diseases.

Avatar - New Atlas
Curated by
New Atlas
    • Life Sciences
    • Biology
    • Science
    • Biotechnology
    • Genetics
America’s first CRISPR trial is still nearly 100% effective 3 years on
Continue to read
11 stories in this Storyboard

Related articles

More stories from Life Sciences